Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase

Journal of Lipid Research

Volumn 47, Issue 5, 2006, Pages 1054-1062

  Huber, Joakim ^a   Fürnkranz, Alexander ^a   Bochkov, Valery N ^a   Patricia, Mary K ^b   Lee, Hans ^b   Hedrick, Catherine C ^c   Berliner, Judith A ^b   Binder, Bernd R ^a   Leitinger, Norbert ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

12 lipoxygenase; Atherosclerosis; Cytosolic phospholipase A2; Endothelial cells

Indexed keywords

ANIMALS; ARACHIDONIC ACID; CELL ADHESION; CELLS, CULTURED; CYTOSOL; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; LIPOXYGENASE; MAP KINASE SIGNALING SYSTEM; MICE; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A; PHOSPHOLIPID ETHERS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 33646780193     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500555-JLR200     Document Type: Article

References (47)

1. Lusis, A. J. 2000. Atherosclerosis. Nature. 407: 233-241.
2. Berliner, J. A., M. C. Territo, A. Sevanian, S. Ramin, J. A. Kim, B. Bamshad, M. Esterson, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1260-1266.
3. Berliner, J., N. Leitinger, A. Watson, J. Huber, A. Fogelman, and M. Navab. 1997. Oxidized lipids in atherogenesis: formation, destruction and action. Thromb. Haemost. 78: 195-199.
4. Watson, A. D., N. Leitinger, M. Navab, K. F. Faull, S. Horkko, J. L. Witztum, W. Palinski, D. Schwenke, R. G. Salomon, W. Sha, et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272: 13597-13607.
5. Subbanagounder, G., N. Leitinger, D. C. Schwenke, J. W. Wong, H. Lee, C. Rizza, A. D. Watson, K. F. Faull, A. M. Fogelman, and J. A. Berliner. 2000. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 20: 2248-2254.
6. Huber, J., A. Vales, G. Mitulovic, M. Blumer, R. Schmid, J. L. Witztum, B. R. Binder, and N. Leitinger. 2002. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler. Thromb. Vasc. Biol. 22: 101-107.
7. Chang, M. K., C. J. Binder, Y. I. Miller, G. Subbanagounder, G. J. Silverman, J. A. Berliner, and J. L. Witztum. 2004. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200: 1359-1370.
8. Huber, J., H. Boechzelt, B. Karten, M. Surboeck, V. N. Bochkov, B. R. Binder, W. Sattler, and N. Leitinger. 2002. Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway. Arterioscler. Thromb. Vasc. Biol. 22: 581-586.
9. Bochkov, V. N., D. Mechtcheriakova, M. Lucerna, J. Huber, R. Malli, W. F. Graier, E. Hofer, B. R. Binder, and N. Leitinger. 2002. Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT. Blood. 99: 199-206.
10. Yeh, M., N. Leitinger, R. de Martin, N. Onai, K. Matsushima, D. K. Vora, J. A. Berliner, and S. T. Reddy. 2001. Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 21: 1585-1591.
11. Shih, P. T., M. J. Elices, Z. T. Fang, T. P. Ugarova, D. Strahl, M. C. Territo, J. S. Frank, N. L. Kovach, C. Cabanas, J. A. Berliner, et al. 1999. Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta1 integrin. J. Clin. Invest. 103: 613-625.
12. Leitinger, N., T. R. Tyner, L. Oslund, C. Rizza, G. Subbanagounder, H. Lee, P. T. Shih, N. Mackman, G. Tigyi, M. C. Territo, et al. 1999. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc. Natl. Acad. Sci. USA. 96: 12010-12015.
13. Cole, A. L., G. Subbanagounder, S. Mukhopadhyay, J. A. Berliner, and D. K. Vora. 2003. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway. Arterioscler. Thromb. Vasc. Biol. 23: 1384-1390.
14. Honda, H. M., N. Leitinger, M. Frankel, J. I. Goldhaber, R. Natarajan, J. L. Nadler, J. N. Weiss, and J. A. Berliner. 1999. Induction of monocyte binding to endothelial cells by MM-LDL: role of lipoxygenase metabolites. Arterioscler. Thromb. Vasc. Biol. 19: 680-686.
15. Lee, H., W. Shi, P. Tontonoz, S. Wang, G. Subbanagounder, C. C. Hedrick, S. Hama, C. Borromeo, R. M. Evans, J. A. Berliner, et al. 2000. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ. Res. 87: 516-521.
16. Zhang, J. C., A. Fabry, L. Paucz, J. Wojta, and B. R. Binder. 1996. Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cells. Blood. 88: 3880-3886.
17. Leitinger, N., J. Huber, C. Rizza, D. Mechtcheriakova, V. Bochkov, Y. Koshelnick, J. A. Berliner, and B. R. Binder. 2001. The isoprostane 8-iso-PGF(2alpha) stimulates endothelial cells to bind monocytes: differences from thromboxane-mediated endothelial activation. FASEB J. 15: 1254-1256.
18. Shi, W., N. J. Wang, D. M. Shih, V. Z. Sun, X. Wang, and A. J. Lusis. 2000. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ. Res. 86: 1078-1084.
19. Tsao, P. S., L. M. McEvoy, H. Drexler, E. C. Butcher, and J. P. Cooke. 1994. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 89: 2176-2182.
20. Krebs, M., C. Kaun, M. Lorenz, M. Haag-Weber, M. Geiger, and B. R. Binder. 1999. Protease dependent activation of endothelial cells by peritoneal dialysis effluents. Thromb. Haemost. 82: 1334-1341.
21. Tran, K., J. T. Wong, E. Lee, A. C. Chan, and P. C. Choy. 1996. Vitamin E potentiates arachidonate release and phospholipase A2 activity in rat heart myoblastic cells. Biochem. J. 319: 385-391.
22. Gu, J. L., D. Veerapanane, J. Rossi, R. Natarajan, L. Thomas, and J. Nadler. 1995. Ribozyme-mediated inhibition of expression of leukocyte-type 12-lipoxygenase in porcine aortic vascular smooth muscle cells. Circ. Res. 77: 14-20.
23. Gu, J. L., H. Pei, L. Thomas, J. L. Nadler, J. J. Rossi, L. Lanting, and R. Natarajan. 2001. Ribozyme-mediated inhibition of rat leukocyte-type 12-lipoxygenase prevents intimal hyperplasia in balloon-injured rat carotid arteries. Circulation. 103: 1446-1452.
24. Gu, J. L., J. Nadler, and J. Rossi. 1997. Use of a hammerhead ribozyme with cationic liposomes to reduce leukocyte type 12-lipoxygenase expression in vascular smooth muscle. Mol. Cell. Biochem. 172: 47-57.
25. Patricia, M. K., R. Natarajan, A. N. Dooley, F. Hernandez, J. L. Gu, J. A. Berliner, J. J. Rossi, J. L. Nadler, R. S. Meidell, and C. C. Hedrick. 2001. Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells. Circ. Res. 88: 659-665.
26. Watson, A. D., M. Navab, S. Y. Hama, A. Sevanian, S. M. Prescott, D. M. Stafforini, T. M. McIntyre, B. N. Du, A. M. Fogelman, and J. A. Berliner. 1995. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95: 774-782.
27. Parhami, F., Z. T. Fang, B. Yang, A. M. Fogelman, and J. A. Berliner. 1995. Stimulation of Gs and inhibition of Gi protein functions by minimally oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 15: 2019-2024.
28. Kolch, W. 2000. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351: 289-305.
29. Sa, G., G. Murugesan, M. Jaye, Y. Ivashchenko, and P. L. Fox. 1995. Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J. Biol. Chem. 270: 2360-2366.
30. Kramer, R. M., E. F. Roberts, S. L. Um, A. G. Borsch-Haubold, S. P. Watson, M. J. Fisher, and J. A. Jakubowski. 1996. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J. Biol. Chem. 271: 27723-27729.
31. Schmidlin, F., S. Loeffler, C. Bertrand, Y. Landry, and J. P. Gies. 2000. PLA2 phosphorylation and cyclooxygenase-2 induction, through p38 MAP kinase pathway, is involved in the IL-1beta-induced bradykinin B2 receptor gene transcription. Naunyn Schmiedebergs Arch. Pharmacol. 361: 247-254.
32. Smith, W. L., 1992. Prostanoid biosynthesis and mechanisms of action. Am. J. Physiol. 263: F181-F191.
33. Salari, H., P. Braquet, and P. Borgeat. 1984. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukot. Med. 13: 53-60.
34. Hatley, M. E., S. Srinivasan, K. B. Reilly, D. T. Bolick, and C. C. Hedrick. 2003. Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice. J. Biol. Chem. 278: 25369-25375.
35. Reilly, K. B., S. Srinivasan, M. E. Hatley, M. K. Patricia, J. Lannigan, D. T. Bolick, G. Vandenhoff, H. Pei, R. Natarajan, J. L. Nadler, et al. 2004. 12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. J. Biol. Chem. 279: 9440-9450.
36. Marx, N., G. K. Sukhova, T. Collins, P. Libby, and J. Plutzky. 1999. PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation. 99: 3125-3131.
37. Witztum, J. L., and J. A. Berliner. 1998. Oxidized phospholipids and isoprostanes in atherosclerosis. Curr. Opin. Lipidol. 9: 441-448.
38. Yeh, M., N. M. Gharavi, J. Choi, X. Hsieh, E. Reed, K. P. Mouillesseaux, A. L. Cole, S. T. Reddy, and J. A. Berliner. 2004. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J. Biol. Chem. 279: 30175-30181.
39. Waterman, W. H., T. F. Molski, C. K. Huang, J. L. Adams, and R. I. Sha'afi. 1996. Tumour necrosis factor-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem. J. 319: 17-20.
40. Lin, L. L., M. Wartmann, A. Y. Lin, J. L. Knopf, A. Seth, and R. J. Davis. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 72: 269-278.
41. George, J., A. Afek, A. Shaish, H. Levkovitz, N. Bloom, T. Cyrus, L. Zhao, C. D. Funk, E. Sigal, and D. Harats. 2001. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation. 104: 1646-1650.
42. Cyrus, T., J. L. Witztum, D. J. Rader, R. Tangirala, S. Fazio, M. F. Linton, and C. D. Funk. 1999. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J. Clin. Invest. 103: 1597-1604.
43. Cyrus, T., D. Pratico, L. Zhao, J. L. Witztum, D. J. Rader, J. Rokach, G. A. FitzGerald, and C. D. Funk. 2001. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice. Circulation. 103: 2277-2282.
44. Zhao, L., and C. D. Funk. 2004. Lipoxygenase pathways in atherogenesis. Trends Cardiovasc. Med. 14: 191-195.
45. Tordjman, K., C. Bernal-Mizrachi, L. Zemany, S. Weng, C. Feng, F. Zhang, T. C. Leone, T. Coleman, D. P. Kelly, and C. F. Semenkovich. 2001. PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J. Clin. Invest. 107: 1025-1034.
46. Delerive, P., C. Furman, E. Teissier, J. Fruchart, P. Duriez, and B. Staels. 2000. Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner. FEBS Lett. 471: 34-38.
47. Muller, W. A. 2002. Leukocyte-endothelial cell interactions in the inflammatory response. Lab. Invest. 82: 521-533.